Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Mesenchymal Stem/Stromal Cells
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Cell Culture Media & Supplements
      • Serum
      • Xeno-free
      • cGMP CliniControl™
    • Exosomes/Extracellular Vesicles
      • Media & Supplements
      • cGMP CliniControl™ Production Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor Screening Kits
      • Bioreactor Kits & Bundles
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem/Stromal Cells
      • Cell Culture Media & Supplements
      • Exosome/Extracellular Vesicle Production Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Search Publications

Therapeutic Indication

Tech Segment

Reset

Expression Profiling of Mitochondria-associated microRNAs During Osteogenic Differentiation of Human MSCs

June 2021

A Chemically Defined, Xeno & Blood-free Culture Medium Sustains Increased Production of Small Extracellular Vesicles from Mesenchymal Stem Cells

June 2021 Blood, EVs & MSC Secretome

Physiologically Relevant Fluid-Induced Oscillatory Shear Stress Stimulation of Mesenchymal Stem Cells Enhances the Engineered Valve Matrix Phenotype

June 2021 Cardiovascular, EVs & MSC Secretome, Tissue & Organ Engineering

Characterizing Human Mesenchymal Stromal Cells Immune Modulatory Potency Using Targeted Lipidomic Profiling of Sphingolipids

June 2021 Drug Screening, Immunomodulation

The Glucagon-like Peptide 1 Receptor Agonist Exendin-4 Induces Tenogenesis in Human Mesenchymal Stem Cells

June 2021 Diabetes

Minimal Effects of Intravenous Administration of Xenogeneic Adipose Derived Stem Cells on Organ Function in a Porcine 40% TBSA Burn Model

June 2021 Cell Therapy, Immunomodulation, Tissue & Organ Engineering

Multi-omics Characterization of Mesenchymal Stem/stromal Cells for the Identification of Putative Critical Quality Attributes

May 2021 Drug Screening

Enhancing hMSC Extracellular Vesicle Productivity with a Novel Collection Media for Scalable MSC-EV Generation

May 2021 EVs & MSC Secretome

Large Scale Manufacturing & Potency Assay Development for hmscs in Regenerative Medicine

May 2021

Comparison of the Therapeutic Potential of Human & Rats Mesenchymal Stem Cells & Their Conditioned Medium with Local Radiation Injuries

May 2021 Cell Therapy
Previous 1 2 3 4 5 6 7 8 9 … 23 24 25 26 Next

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Mesenchymal Stem/Stromal Cells
    • Cell Culture Media & Supplements
    • Exosomes/Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2022 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email